source
- Galapagos spinout Coultreon raises $125M for new take on SIK inhibitionCoultreon Biopharma has patched together $125 million from some of the largest biotech investors in the US and Europe in a bid to join the burgeoning pipeline-in-a-pill approach to autoimmune disea…Endpoints · 3mo ago↗ source
- STAT+: Eli Lilly enlists AI startup for next-generation gene editorsEli Lilly's deal with Profluent aims to go beyond CRISPR by using AI-designed enzymes to insert entire genes. It could reshape genetic medicine.STAT · 3mo ago↗ source
- Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spendingNovartis CEO Vas Narasimhan said the Swiss company is “very disappointed” by Germany’s plan to shave off more than €60 billion in healthcare costs that would affect pharma sales. Germany wants to s…